Company Search:
Advanced Search
Sponsored Links
Chimerix Inc Company Snapshot
Chimerix Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chimerix Inc with three other companies in this sector in UNITED STATES : ProPhase Labs Inc (2019 sales of $9.88 million ), China Pharma Holdings, Inc. ($10.92 million ), and Dbv Technologies ($14.69 million of which 100% was research and development of epicutaneous).

Sales Analysis. Chimerix Inc reported sales of $12.52 million for the year ending December of 2019. This represents an increase of 73.5% versus 2018, when the company's sales were $7.22 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Chimerix Inc
  Stock Performance Chart for Chimerix Inc
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 3.41
(Figures in U.S. Dollars)
1 Week 9.6%   13 Weeks 11.4%  
4 Weeks 16.4%   52 Weeks 19.6%  
Chimerix Inc Key Data:
  Ticker: CMRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 12,519,000
(Year Ending Jan 2020).
Employees: 43
  Currency: U.S. Dollars Market Cap: 211,182,456
  Fiscal Yr Ends: December Shares Outstanding: 61,930,339
  Share Type: Common Closely Held Shares: 11,484,802
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.